These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3323092)

  • 61. Photoreactive insulin analogues used to characterise the insulin receptor.
    Wisher MH; Baron MD; Jones RH; Sönksen PH
    Biochem Biophys Res Commun; 1980 Jan; 92(2):492-8. PubMed ID: 6986869
    [No Abstract]   [Full Text] [Related]  

  • 62. Cross-linked [DAlaA1]Insulins. Evidence for a change in the conformation of the insulin monomer at its receptor.
    Saunders D; Freude K
    Hoppe Seylers Z Physiol Chem; 1982 Jun; 363(6):655-9. PubMed ID: 7049891
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Immunoreactivity and biologic activity of semisynthetic [LeuB-30]-insulin: potential value in the treatment of insulin antibody-mediated insulin resistance.
    Kobayashi M; Ohgaku S; Iwasaki M; Shigeta Y; Oka T; Morihara K
    Diabetes; 1981 Jun; 30(6):519-23. PubMed ID: 7014315
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Photoreactive insulin derivatives. Comparison of biologic activity and labeling properties of three analogues in isolated rat adipocytes.
    Wang CC; Hedo JA; Kahn CR; Saunders DT; Thamm P; Brandenburg D
    Diabetes; 1982 Dec; 31(12):1068-76. PubMed ID: 6757019
    [No Abstract]   [Full Text] [Related]  

  • 65. Degradation, receptor binding affinity and biological potency of monoiodoinsulin in isolated rat fat cells.
    Gammeltoft S; Vinten J; Gliemann J; Linde S
    Horm Metab Res; 1977 May; 9(3):186-9. PubMed ID: 885469
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Effect of pH and buffers on insulin binding to normal and neoplastic mammary cells, fat cells and membrane preparations.
    Shafie SM; Cech JM; Livingston JN; Hilf R
    Cancer Biochem Biophys; 1979; 4(2):51-7. PubMed ID: 45221
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Biological properties of chemically modified insulins. I. Biological activity of proinsulin and insulin modified at A1-glycine and B29-lysine.
    Jones RH; Dron DI; Ellis MJ; Sönksen PH; Brandenburg D
    Diabetologia; 1976 Dec; 12(6):601-8. PubMed ID: 1001848
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Covalent linking of photoreactive insulin to adipocytes produces a prolonged signal.
    Brandenburg D; Diaconescu C; Saunders D; Thamm P
    Nature; 1980 Aug; 286(5775):821-2. PubMed ID: 6995859
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The biological potency of covalent insulin-receptor complexes. Dependence on site of cross-linkage.
    Klotz G; Saunders DJ; Brandenburg D
    Hoppe Seylers Z Physiol Chem; 1984 Apr; 365(4):493-8. PubMed ID: 6376321
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Bradykinin-induced alterations of insulin-receptor interaction in rat adipose tissue under normo- and hypothermic conditions.
    Gibas M; Torlińska T; Madry E; Maćkowlak P
    Med Sci Monit; 2004 Apr; 10(4):BR109-14. PubMed ID: 15039640
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Evidence for surface glycoprotein involvement in the intracellular bioactivity of insulin in rat adipocytes.
    Cherqui G; Caron M; Capeau J; Picard J
    Biochem J; 1983 Jul; 214(1):111-20. PubMed ID: 6351847
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Effect of hypothermia on the insulin-receptor interaction in adipose plasma membranes.
    Torlińska T; Maćkowiak P; Nogowski L; Koźlik J
    J Physiol Pharmacol; 1995 Sep; 46(3):341-9. PubMed ID: 8527815
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Receptor binding and biological activity of [SerB24]-insulin, an abnormal mutant insulin.
    Kobayashi M; Haneda M; Maegawa H; Watanabe N; Takada Y; Shigeta Y; Inouye K
    Biochem Biophys Res Commun; 1984 Feb; 119(1):49-57. PubMed ID: 6367745
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Structural features involved in the biological activity of insulin and the insulin-like growth factors: A27 insulin/BIGF-I.
    Joshi S; Ogawa H; Burke GT; Tseng LY; Rechler MM; Katsoyannis PG
    Biochem Biophys Res Commun; 1985 Dec; 133(2):423-9. PubMed ID: 3002339
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Receptor binding and biological potency of despentapeptide insulin.
    Taylor R; Hetherington CS; Tolley S
    Horm Metab Res; 1989 May; 21(5):249-52. PubMed ID: 2673959
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Modification of the insulin receptor by diethyl pyrocarbonate: effect on insulin binding and action.
    Pilch PF
    Biochemistry; 1982 Oct; 21(22):5638-44. PubMed ID: 6756473
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hormone binding alters the conformation of the insulin receptor.
    Pilch PF; Czech MP
    Science; 1980 Dec; 210(4474):1152-3. PubMed ID: 7003712
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Receptor binding and negative cooperativity of a mutant insulin, [LeuA3]-insulin.
    Kobayashi M; Takata Y; Ishibashi O; Sasaoka T; Iwasaki TM; Shigeta Y; Inouye K
    Biochem Biophys Res Commun; 1986 May; 137(1):250-7. PubMed ID: 3521604
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A highly potent insulin: des-(B26-B30)-[AspB10,TyrB25-NH2]insulin(human).
    Schwartz GP; Burke GT; Katsoyannis PG
    Proc Natl Acad Sci U S A; 1989 Jan; 86(2):458-61. PubMed ID: 2643113
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Steric requirements at position B12 for high biological activity in insulin.
    Hu SQ; Burke GT; Schwartz GP; Ferderigos N; Ross JB; Katsoyannis PG
    Biochemistry; 1993 Mar; 32(10):2631-5. PubMed ID: 8448120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.